Heron Therapeutics, Inc.
Heron Therapeutics, Inc. (0J4V.L) Stock Overview
Explore Heron Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
205.4M
P/E Ratio
-15.85
EPS (TTM)
$-2.29
ROE
0.37%
0J4V.L Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Heron Therapeutics, Inc. (0J4V.L) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 36.50, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.34.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -15.85 and a market capitalization of 205.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.